KAM
KEB Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
1,711
-79
| -4% | -$14.7K | 0.08% | 72 |
|
|
2025
Q1 | $375K | Sell |
1,790
-83
| -4% | -$17.4K | 0.11% | 57 |
|
|
2024
Q4 | $333K | Buy |
1,873
+241
| +15% | +$42.8K | 0.1% | 58 |
|
|
2024
Q3 | $322K | Sell |
1,632
-392
| -19% | -$77.4K | 0.1% | 59 |
|
|
2024
Q2 | $347K | Buy |
2,024
+4
| +0.2% | +$686 | 0.12% | 52 |
|
|
2024
Q1 | $368K | Buy |
2,020
+5
| +0.2% | +$910 | 0.13% | 47 |
|
|
2023
Q4 | $312K | Sell |
2,015
-853
| -30% | -$132K | 0.12% | 50 |
|
|
2023
Q3 | $428K | Sell |
2,868
-51
| -2% | -$7.6K | 0.18% | 35 |
|
|
2023
Q2 | $393K | Buy |
2,919
+1,609
| +123% | +$217K | 0.16% | 36 |
|
|
2023
Q1 | $209K | Hold |
1,310
| – | – | 0.09% | 56 |
|
|
2022
Q4 | $212K | Buy |
+1,310
| New | +$212K | 0.11% | 56 |
|
|
2022
Q3 | – | Sell |
-1,310
| Closed | -$201K | – | 55 |
|
|
2022
Q2 | $201K | Buy |
+1,310
| New | +$201K | 0.13% | 53 |
|